SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Oppenheimer Maintains Outperform on AtriCure, Raises Price Target to $52

Oppenheimer maintains AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $45 to $52.

Benzinga · 05/11/2020 11:39

Oppenheimer maintains AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $45 to $52.